GIANFALDONI, GIACOMO
GIANFALDONI, GIACOMO
AREA CRITICA MEDICO CHIRURGICA (attivo dal 01/01/2000 al 31/12/2012)
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance – MYNERVA-GIMEMA AML1919 trial
2021 Mannelli, Francesco; Gianfaldoni, Giacomo; Guglielmelli, Paola; Buccisano, Francesco; Caporale, Roberto; Chiarini, Marco; Rossi, Giuseppe; Venditti, Adriano; Fazi, Paola; Crea, Enrico; Piciocchi, Alfonso; Voso, Maria Teresa; Vignetti, Marco; Amadori, Sergio; Vannucchi, Alessandro Maria
CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease.
2011 Mannelli F;Gianfaldoni G;Intermesoli T;Cattaneo C;Borlenghi E;Cortelazzo S;Cavattoni I;Pogliani EM;Fumagalli M;Angelucci E;Romani C;Ciceri F;Corti C;Scattolin AM;Cortelezzi A;Mattei D;Audisio E;Spinelli O;Oldani E;Bosi A;Rambaldi A;Bassan R
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
2014 Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Sara Bencini, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Maria Ida Bonetti, Caterina Biagiotti, Giovanni Longo, Alberto Bosi
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients.
2012 Scappini B;Gianfaldoni G;Caracciolo F;Mannelli F;Biagiotti C;Romani C;Pogliani EM;Simonetti F;Borin L;Fanci R;Cutini I;Longo G;Susini MC;Angelucci E;Bosi A
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in AML
2020 Mannelli, Francesco; Gianfaldoni, Giacomo; Bencini, Sara; Piccini, Matteo; Cutini, Ilaria; Bonetti, Maria Ida; Scappini, Barbara; Pancani, Fabiana; Ponziani, Vanessa; Chiarini, Marco; Borlenghi, Erika; Bassan, Renato; Rossi, Giuseppe; Bosi, Alberto
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial
2020 Gianfaldoni, Giacomo; Mannelli, Francesco; Intermesoli, Tamara; Bencini, Sara; Giupponi, Damiano; Farina, Giorgio; Cutini, Ilaria; Bonetti, Maria Ida; Masciulli, Arianna; Audisio, Ernesta; Ferrero, Dario; Pavoni, Chiara; Scattolin, Anna Maria; Bosi, Alberto; Rambaldi, Alessandro; Bassan, Renato
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia.
2010 Gianfaldoni G; Mannelli F; Ponziani V; Longo G; Bencini S; Bosi A; Vannucchi AM.
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia
2023 Mannelli, Francesco; Piccini, Matteo; Bencini, Sara; Gianfaldoni, Giacomo; Peruzzi, Benedetta; Caporale, Roberto; Scappini, Barbara; Fasano, Laura; Quinti, Elisa; Ciolli, Gaia; Pasquini, Andrea; Crupi, Francesca; Pilerci, Sofia; Pancani, Fabiana; Signori, Leonardo; Tarantino, Danilo; Maccari, Chiara; Paradiso, Vivian; Annunziato, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro M
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature
2019 Rinaldi F.; Giache S.; Spinicci M.; Corsi P.; Ambu S.; Gianfaldoni G.; Rigacci L.; Arena U.; Bartoloni A.; Zammarchi L.
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
2019 Innocenti, Rolando; Rigacci, Luigi; Restelli, Umberto; Scappini, Barbara; Gianfaldoni, Giacomo; Fanci, Rosa; Mannelli, Francesco; Scolari, Francesca; Croce, Davide; Bonizzoni, Erminio; Perrone, Tania; Bosi, Alberto
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia
2015 Mannelli, Francesco; Ponziani, Vanessa; Bonetti, Maria Ida; Bencini, Sara; Cutini, Ilaria; Gianfaldoni, Giacomo; Scappini, Barbara; Pancani, Fabiana; Rondelli, Tommaso; Benelli, Matteo; Caporale, Roberto; Grazia Gelli, Anna Maria; Peruzzi, Benedetta; Longo, Giovanni; Bosi, Alberto
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm
2020 Piccini M, Loscocco GG, Gianfaldoni G, Grieco P, Palmieri G, Pilerci S, Scappini B, Bosi A
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
2019 Bassan, Renato; Intermesoli, Tamara; Masciulli, Arianna; Pavoni, Chiara; Boschini, Cristina; Gianfaldoni, Giacomo; Marmont, Filippo; Cavattoni, Irene; Mattei, Daniele; Terruzzi, Elisabetta; De Paoli, Lorella; Cattaneo, Chiara; Borlenghi, Erika; Ciceri, Fabio; Bernardi, Massimo; Scattolin, Anna M; Todisco, Elisabetta; Campiotti, Leonardo; Corradini, Paolo; Cortelezzi, Agostino; Ferrero, Dario; Zanghì, Pamela; Oldani, Elena; Spinelli, Orietta; Audisio, Ernesta; Cortelazzo, Sergio; Bosi, Alberto; Falini, Brunangelo; Pogliani, Enrico M; Rambaldi, Alessandro
THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS
2019 Bartalucci, N; Mannelli, F; Contini, E; Romagnoli, S; Gianfaldoni, G; Scappini, B; Pelo, E; Pancani, F; Magi, A; Bosi, A; Guglielmelli, P; Vannucchi, AM
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience
2021 Piccini, Matteo; Pilerci, Sofia; Merlini, Marta; Grieco, Pietro; Scappini, Barbara; Bencini, Sara; Peruzzi, Benedetta; Caporale, Roberto; Signori, Leonardo; Pancani, Fabiana; Vannucchi, Alessandro Maria; Gianfaldoni, Giacomo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance – MYNERVA-GIMEMA AML1919 trial | 2021 | Mannelli, Francesco; Gianfaldoni, Giacomo; Guglielmelli, Paola; Buccisano, Francesco; Caporale, Roberto; Chiarini, Marco; Rossi, Giuseppe; Venditti, Adriano; Fazi, Paola; Crea, Enrico; Piciocchi, Alfonso; Voso, Maria Teresa; Vignetti, Marco; Amadori, Sergio; Vannucchi, Alessandro Maria | |
| CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease. | 2011 | Mannelli F;Gianfaldoni G;Intermesoli T;Cattaneo C;Borlenghi E;Cortelazzo S;Cavattoni I;Pogliani EM;Fumagalli M;Angelucci E;Romani C;Ciceri F;Corti C;Scattolin AM;Cortelezzi A;Mattei D;Audisio E;Spinelli O;Oldani E;Bosi A;Rambaldi A;Bassan R | |
| CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia. | 2014 | Francesco Mannelli, Ilaria Cutini, Giacomo Gianfaldoni, Sara Bencini, Barbara Scappini, Fabiana Pancani, Vanessa Ponziani, Maria Ida Bonetti, Caterina Biagiotti, Giovanni Longo, Alberto Bosi | |
| Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. | 2012 | Scappini B;Gianfaldoni G;Caracciolo F;Mannelli F;Biagiotti C;Romani C;Pogliani EM;Simonetti F;Borin L;Fanci R;Cutini I;Longo G;Susini MC;Angelucci E;Bosi A | |
| Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in AML | 2020 | Mannelli, Francesco; Gianfaldoni, Giacomo; Bencini, Sara; Piccini, Matteo; Cutini, Ilaria; Bonetti, Maria Ida; Scappini, Barbara; Pancani, Fabiana; Ponziani, Vanessa; Chiarini, Marco; Borlenghi, Erika; Bassan, Renato; Rossi, Giuseppe; Bosi, Alberto | |
| Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial | 2020 | Gianfaldoni, Giacomo; Mannelli, Francesco; Intermesoli, Tamara; Bencini, Sara; Giupponi, Damiano; Farina, Giorgio; Cutini, Ilaria; Bonetti, Maria Ida; Masciulli, Arianna; Audisio, Ernesta; Ferrero, Dario; Pavoni, Chiara; Scattolin, Anna Maria; Bosi, Alberto; Rambaldi, Alessandro; Bassan, Renato | |
| Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia. | 2010 | Gianfaldoni G; Mannelli F; Ponziani V; Longo G; Bencini S; Bosi A; Vannucchi AM. | |
| Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia | 2023 | Mannelli, Francesco; Piccini, Matteo; Bencini, Sara; Gianfaldoni, Giacomo; Peruzzi, Benedetta; Caporale, Roberto; Scappini, Barbara; Fasano, Laura; Quinti, Elisa; Ciolli, Gaia; Pasquini, Andrea; Crupi, Francesca; Pilerci, Sofia; Pancani, Fabiana; Signori, Leonardo; Tarantino, Danilo; Maccari, Chiara; Paradiso, Vivian; Annunziato, Francesco; Guglielmelli, Paola; Vannucchi, Alessandro M | |
| Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature | 2019 | Rinaldi F.; Giache S.; Spinicci M.; Corsi P.; Ambu S.; Gianfaldoni G.; Rigacci L.; Arena U.; Bartoloni A.; Zammarchi L. | |
| Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey | 2019 | Innocenti, Rolando; Rigacci, Luigi; Restelli, Umberto; Scappini, Barbara; Gianfaldoni, Giacomo; Fanci, Rosa; Mannelli, Francesco; Scolari, Francesca; Croce, Davide; Bonizzoni, Erminio; Perrone, Tania; Bosi, Alberto | |
| Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia | 2015 | Mannelli, Francesco; Ponziani, Vanessa; Bonetti, Maria Ida; Bencini, Sara; Cutini, Ilaria; Gianfaldoni, Giacomo; Scappini, Barbara; Pancani, Fabiana; Rondelli, Tommaso; Benelli, Matteo; Caporale, Roberto; Grazia Gelli, Anna Maria; Peruzzi, Benedetta; Longo, Giovanni; Bosi, Alberto | |
| Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm | 2020 | Piccini M, Loscocco GG, Gianfaldoni G, Grieco P, Palmieri G, Pilerci S, Scappini B, Bosi A | |
| Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML | 2019 | Bassan, Renato; Intermesoli, Tamara; Masciulli, Arianna; Pavoni, Chiara; Boschini, Cristina; Gianfaldoni, Giacomo; Marmont, Filippo; Cavattoni, Irene; Mattei, Daniele; Terruzzi, Elisabetta; De Paoli, Lorella; Cattaneo, Chiara; Borlenghi, Erika; Ciceri, Fabio; Bernardi, Massimo; Scattolin, Anna M; Todisco, Elisabetta; Campiotti, Leonardo; Corradini, Paolo; Cortelezzi, Agostino; Ferrero, Dario; Zanghì, Pamela; Oldani, Elena; Spinelli, Orietta; Audisio, Ernesta; Cortelazzo, Sergio; Bosi, Alberto; Falini, Brunangelo; Pogliani, Enrico M; Rambaldi, Alessandro | |
| THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS | 2019 | Bartalucci, N; Mannelli, F; Contini, E; Romagnoli, S; Gianfaldoni, G; Scappini, B; Pelo, E; Pancani, F; Magi, A; Bosi, A; Guglielmelli, P; Vannucchi, AM | |
| Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience | 2021 | Piccini, Matteo; Pilerci, Sofia; Merlini, Marta; Grieco, Pietro; Scappini, Barbara; Bencini, Sara; Peruzzi, Benedetta; Caporale, Roberto; Signori, Leonardo; Pancani, Fabiana; Vannucchi, Alessandro Maria; Gianfaldoni, Giacomo |